• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

((()-1-羧基-5-(6-([F]氟)-2-甲氧基烟酰胺基)戊基)氨基甲酰基)-L-谷氨酸([F]JK-PSMA-7)的全自动生产

Fully Automated Production of ((()-1-Carboxy-5-(6-([F]fluoro)-2-methoxynicotinamido)pentyl)carbamoyl)-l-glutamic Acid ([F]JK-PSMA-7).

作者信息

Krapf Philipp, Wicher Thomas, Zlatopolskiy Boris D, Ermert Johannes, Neumaier Bernd

机构信息

Forschungszentrum Jülich GmbH, Institute of Neuroscience and Medicine, Nuclear Chemistry (INM-5), Wilhelm-Johnen-Str., 52428 Jülich, Germany.

Institute of Radiochemistry and Experimental Molecular Imaging, Faculty of Medicine and University Hospital Cologne, University of Cologne, Kerpener Str. 62, 50937 Cologne, Germany.

出版信息

Pharmaceuticals (Basel). 2025 Jan 17;18(1):119. doi: 10.3390/ph18010119.

DOI:10.3390/ph18010119
PMID:39861180
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11769433/
Abstract

The radiotracer [F]JK-PSMA-7, a prostate cancer imaging agent for positron emission tomography (PET), was previously synthesized by indirect radiofluorination using an F-labeled active ester as a prosthetic group, which had to be isolated and purified before it could be linked to the pharmacologically active Lys-urea-Glu motif. Although this procedure could be automated on two-reactor modules like the GE TRACERLab FX2N (FXN) to afford the tracer in modest radiochemical yields (RCY) of 18-25%, it is unsuitable for cassette-based systems with a single reactor. To simplify implementation on an automated synthesis module, the radiosynthesis of [F]JK-PSMA-7 was devised as a one-pot, two-step reaction. The new method is based on direct ("late-stage") radiofluorination of an appropriate onium triflate precursor and subsequent deprotection with -phosphoric acid. It was successfully established on the cassette-based Trasis AllInOne (AIO) module. Overall, the new protocol enabled the production of [F]JK-PSMA-7 in activity yields of 39 ± 4% (RCY = 58%) with an overall synthesis time of about 1 h. In a single production run with an initial activity of 36-43 GBq, 13-19 GBq of [F]JK-PSMA-7 with a radiochemical purity of >99% was obtained. We have established a highly reliable, GMP-compliant process for the automated radiosynthesis of [F]JK-PSMA-7 on the Trasis AllinOne (AIO) synthesizer, ensuring consistent and efficient production of this radioligand.

摘要

放射性示踪剂[F]JK-PSMA-7是一种用于正电子发射断层扫描(PET)的前列腺癌成像剂,此前是通过间接放射性氟化法合成的,使用F标记的活性酯作为辅基,在将其与具有药理活性的Lys-urea-Glu基序连接之前,必须进行分离和纯化。尽管该过程可以在GE TRACERLab FX2N(FXN)等双反应器模块上实现自动化,以18%-25%的适度放射化学产率(RCY)获得示踪剂,但它不适用于单反应器的基于盒式的系统。为了简化在自动化合成模块上的实施,[F]JK-PSMA-7的放射合成设计为一锅两步反应。新方法基于对合适的三氟甲磺酸鎓前体进行直接(“后期”)放射性氟化,随后用磷酸脱保护。它已在基于盒式的Trasis AllInOne(AIO)模块上成功建立。总体而言,新方案能够以39±4%的活度产率(RCY = 58%)生产[F]JK-PSMA-7,总合成时间约为1小时。在一次初始活度为36-43 GBq的单次生产运行中,获得了13-19 GBq的[F]JK-PSMA-7,放射化学纯度>99%。我们已经在Trasis AllinOne(AIO)合成器上建立了一个高度可靠、符合GMP的[F]JK-PSMA-7自动化放射合成工艺,确保了这种放射性配体的一致和高效生产。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fff9/11769433/f7a98c53e9c4/pharmaceuticals-18-00119-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fff9/11769433/a45cf3282164/pharmaceuticals-18-00119-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fff9/11769433/3351f0d60240/pharmaceuticals-18-00119-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fff9/11769433/cd2e09bf4ba7/pharmaceuticals-18-00119-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fff9/11769433/0a8a0c92fab6/pharmaceuticals-18-00119-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fff9/11769433/f7a98c53e9c4/pharmaceuticals-18-00119-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fff9/11769433/a45cf3282164/pharmaceuticals-18-00119-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fff9/11769433/3351f0d60240/pharmaceuticals-18-00119-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fff9/11769433/cd2e09bf4ba7/pharmaceuticals-18-00119-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fff9/11769433/0a8a0c92fab6/pharmaceuticals-18-00119-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fff9/11769433/f7a98c53e9c4/pharmaceuticals-18-00119-g005.jpg

相似文献

1
Fully Automated Production of ((()-1-Carboxy-5-(6-([F]fluoro)-2-methoxynicotinamido)pentyl)carbamoyl)-l-glutamic Acid ([F]JK-PSMA-7).((()-1-羧基-5-(6-([F]氟)-2-甲氧基烟酰胺基)戊基)氨基甲酰基)-L-谷氨酸([F]JK-PSMA-7)的全自动生产
Pharmaceuticals (Basel). 2025 Jan 17;18(1):119. doi: 10.3390/ph18010119.
2
Fully automated production of the fibroblast activation protein radiotracer [ F]FAPI-74.全自动生产成纤维细胞激活蛋白放射性示踪剂 [ F]FAPI-74。
J Labelled Comp Radiopharm. 2021 Jun 30;64(8):346-352. doi: 10.1002/jlcr.3926. Epub 2021 May 29.
3
GMP-compliant automated radiosynthesis of [F] SynVesT-1 for PET imaging of synaptic vesicle glycoprotein 2 A (SV2A).用于突触囊泡糖蛋白2A(SV2A)正电子发射断层显像(PET)成像的[F] SynVesT-1的符合药品生产质量管理规范(GMP)的自动化放射性合成。
EJNMMI Radiopharm Chem. 2024 Sep 10;9(1):66. doi: 10.1186/s41181-024-00284-w.
4
Fully automated radiosynthesis of [F]LBT999 on TRACERlab FX and AllinOne modules, a PET radiopharmaceutical for imaging the dopamine transporter in human brain.在TRACERlab FX和一体化模块上对用于人脑多巴胺转运体成像的正电子发射断层显像(PET)放射性药物[F]LBT999进行全自动放射性合成。
EJNMMI Radiopharm Chem. 2020 Nov 16;5(1):26. doi: 10.1186/s41181-020-00105-w.
5
Automated [F]PSMA-1007 production by a single use cassette-type synthesizer for clinical examination.用于临床检查的一次性盒式合成器自动生产[F]PSMA - 1007
EJNMMI Radiopharm Chem. 2020 Jul 29;5(1):18. doi: 10.1186/s41181-020-00101-0.
6
Optimised GMP-compliant production of [F]DPA-714 on the Trasis AllinOne module.在Trasis一体化模块上符合药品生产质量管理规范(GMP)的[F]DPA - 714优化生产。
EJNMMI Radiopharm Chem. 2021 May 26;6(1):20. doi: 10.1186/s41181-021-00133-0.
7
Synthesis and positron emission tomography evaluation of F-Glu-Urea-Lys, a prostate-specific membrane antigen-based imaging agent for prostate cancer.用于前列腺癌的基于前列腺特异性膜抗原的成像剂F-Glu-Urea-Lys的合成及正电子发射断层扫描评估
Oncol Lett. 2015 Oct;10(4):2299-2302. doi: 10.3892/ol.2015.3625. Epub 2015 Aug 19.
8
Automated synthesis of [(18)F]DCFPyL via direct radiofluorination and validation in preclinical prostate cancer models.通过直接放射性氟化自动合成[(18)F]DCFPyL及其在临床前前列腺癌模型中的验证
EJNMMI Res. 2016 Dec;6(1):40. doi: 10.1186/s13550-016-0195-6. Epub 2016 May 4.
9
Compact and cGMP-compliant automated synthesis of [F]FSPG on the Trasis AllinOne™.在Trasis AllinOne™上实现紧凑且符合cGMP标准的[F]FSPG自动化合成。
EJNMMI Radiopharm Chem. 2025 Jan 17;10(1):2. doi: 10.1186/s41181-024-00322-7.
10
Optimization and scale up of production of the PSMA imaging agent [F]AlF-P16-093 on a custom automated radiosynthesis platform.在定制的自动化放射性合成平台上对PSMA成像剂[F]AlF-P16-093进行生产优化及扩大规模
EJNMMI Radiopharm Chem. 2024 Feb 23;9(1):15. doi: 10.1186/s41181-024-00247-1.

本文引用的文献

1
Radiopharmaceutical good practices: Regulation between hospital and industry.放射性药物良好规范:医院与行业之间的监管
Front Nucl Med. 2022 Sep 7;2:990330. doi: 10.3389/fnume.2022.990330. eCollection 2022.
2
Radiopharmaceutical small-scale preparation in Europe: will we be able to harmonize the situation?欧洲放射性药物的小规模制备:我们能够使情况协调一致吗?
EJNMMI Radiopharm Chem. 2024 Sep 5;9(1):64. doi: 10.1186/s41181-024-00281-z.
3
Prostate-specific Membrane Antigen: Diagnostics.前列腺特异性膜抗原:诊断学
PET Clin. 2024 Jul;19(3):351-362. doi: 10.1016/j.cpet.2024.03.001. Epub 2024 May 3.
4
A systematic review on the current status of PSMA-targeted imaging and radioligand therapy.PSMA 靶向成像和放射性配体治疗的现状系统评价。
Eur J Med Chem. 2024 Jan 5;263:115966. doi: 10.1016/j.ejmech.2023.115966. Epub 2023 Nov 17.
5
An Explorative Study of the Incidental High Renal Excretion of [F]PSMA-1007 for Prostate Cancer PET/CT Imaging.[F]PSMA - 1007在前列腺癌PET/CT成像中意外高肾排泄的探索性研究
Cancers (Basel). 2022 Apr 21;14(9):2076. doi: 10.3390/cancers14092076.
6
EANM guideline on quality risk management for radiopharmaceuticals.EANM 放射性药物质量风险管理指南。
Eur J Nucl Med Mol Imaging. 2022 Aug;49(10):3353-3364. doi: 10.1007/s00259-022-05738-4. Epub 2022 Apr 7.
7
Radiolabeled PSMA Inhibitors.放射性标记的前列腺特异性膜抗原(PSMA)抑制剂
Cancers (Basel). 2021 Dec 13;13(24):6255. doi: 10.3390/cancers13246255.
8
Fully automated production of the fibroblast activation protein radiotracer [ F]FAPI-74.全自动生产成纤维细胞激活蛋白放射性示踪剂 [ F]FAPI-74。
J Labelled Comp Radiopharm. 2021 Jun 30;64(8):346-352. doi: 10.1002/jlcr.3926. Epub 2021 May 29.
9
Optimised GMP-compliant production of [F]DPA-714 on the Trasis AllinOne module.在Trasis一体化模块上符合药品生产质量管理规范(GMP)的[F]DPA - 714优化生产。
EJNMMI Radiopharm Chem. 2021 May 26;6(1):20. doi: 10.1186/s41181-021-00133-0.
10
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.《全球癌症统计数据 2020:全球 185 个国家和地区 36 种癌症的发病率和死亡率估计》。
CA Cancer J Clin. 2021 May;71(3):209-249. doi: 10.3322/caac.21660. Epub 2021 Feb 4.